Edition:
United Kingdom

Reata Pharmaceuticals Inc (RETA.OQ)

RETA.OQ on NASDAQ Stock Exchange Global Market

85.44USD
21 Sep 2018
Change (% chg)

$-6.31 (-6.88%)
Prev Close
$91.75
Open
$91.74
Day's High
$91.74
Day's Low
$84.04
Volume
80,926
Avg. Vol
107,912
52-wk High
$93.93
52-wk Low
$19.32

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 7.57 -1.078
Mar '18 32.39 0.153
FY 2017 Dec '17 9.96 -0.638
Sep '17 12.56 -0.495
Jun '17 12.81 -0.518
Mar '17 12.73 -0.318
FY 2016 Dec '16 12.50 -0.185
Sep '16 12.55 -0.040
Jun '16 12.37 -0.050
Mar '16 12.44 -0.013
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 6 10.08 12.50 7.55 9.71
Quarter Ending Dec-18 6 9.73 12.50 7.55 9.71
Year Ending Dec-18 6 59.78 65.00 55.06 46.93
Year Ending Dec-19 6 44.06 59.31 28.90 81.32
Earnings (per share)
Quarter Ending Sep-18 7 -0.78 -0.57 -1.12 -0.46
Quarter Ending Dec-18 7 -0.76 -0.33 -1.12 -0.46
Year Ending Dec-18 7 -2.47 -1.91 -3.16 -2.20
Year Ending Dec-19 7 -3.28 -2.48 -3.98 -3.02
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.70 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) 16.46 114.98 5.74
Price to Book (MRQ) -- 15.51 5.00
Price to Tangible Book (MRQ) -- 14.62 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 38.46 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 3.56 411.53 8.01
Sales (TTM) vs TTM 1 Yr. Ago 1.53 80.36 5.63
Sales - 5 Yr. Growth Rate -- 32.26 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -927.87 29.14 20.61
EPS (TTM) vs TTM 1 Yr. Ago -792.05 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.42 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 1.34 5.46 3.03
LT Debt to Equity (MRQ) -- 35.27 12.51
Total Debt to Equity (MRQ) -- 37.09 16.85
Interest Coverage (TTM) -- -102.34 32.65

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.18 54.37
Gross Margin - 5 Yr. Avg. -- 50.58 52.17
EBITD Margin (TTM) -45.39 -- --
EBITD - 5 Yr. Avg -- -600.62 10.68
Operating Margin (TTM) -46.57 -759.72 4.32
Operating Margin - 5 Yr. Avg. -- -621.65 6.11
Pre-Tax Margin (TTM) -46.88 -733.57 5.18
Pre-Tax Margin - 5 Yr. Avg. -- -627.35 6.51
Net Profit Margin (TTM) -46.89 -734.94 1.48
Net Profit Margin - 5 Yr. Avg. -- -630.39 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 674,533 23,228,954 860,374,110
Net Income/Employee (TTM) -316,293 3,144,136 101,207,069
Receivable Turnover (TTM) -- 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.54 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -25.54 -0.15 11.13
Return on Assets - 5 Yr. Avg. -- 3.51 12.40
Return on Investment (TTM) -63.77 1.78 14.61
Return on Investment - 5 Yr. Avg. -- 2.56 16.13
Return on Equity (TTM) -- 3.27 16.33
Return on Equity - 5 Yr. Avg. -- 3.43 17.39
  1 Year 3 Year 5 Year
Sales % -0.92 -0.88 --
EPS (TTM) % -333.36 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Reata Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 53.78%
# of Holders: 143
Total Shares Held: 12,763,864
3 Mo. Net Change: 895,800
# New Positions: 25
# Closed Positions: 15
# Increased Positions: 88
# Reduced Positions: 42
# Net Buyers: 46
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.